<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=491489&amp;fmt=gif">
Campus Community & Careers
Interview, Testimonial

Q&A: introducing you to G-Therapeutics

May 18, 2016 12:51:40 PM. By: Kim Voets

Sjaak Deckers, CEO G-Therapeutics, www. Gtherapeutics.com.

Who are you?
After working at Philips, I created Sapiens, a startup developing novel Deep Brain Stimulation technology. After acquisition by Medtronic, I moved on to work together with Professor Courtine from the technical university in Lausanne and his team to find financing for G-Therapeutics.

What does your company do?
G-Therapeutics is a spin-off company from Professor Courtine’s laboratory at the École Polytechnique Fédérale de Lausanne (EPFL, Switzerland), with offices in Switzerland and the Netherlands. The Company is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI). The initial focus of G-Therapeutics will be paraplegic patients with incomplete SCI due to a lesion in the cervical or thoracic segments of the spinal cord.

What are your key challenges?
Finding excellent new employees with ample experience in Active Implantable Medical Devices, to develop our exciting neurostimulation product.

Why are you located on the Campus?
Because of the international allure, eco-system of other companies and a good infrastructure.

Interested in our available Office Space?  Contact us for the possibilities and join the Campus hightech ecosystem and  smartest square kilometer of Europe Download our Office Space brochures  

Related items

More news & stories



You're using an old browser
The support for your browser is limited. To enhance your internet experience it's recommended to update your browser. Update browser now!

×